Press release
May 12th Deadline in Lawsuit for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) coming up
A Deadline is coming up on May 12, 2020 in the lawsuit for certain investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO).
Investors who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and there are strict and short deadlines running. Deadline: May 12, 2020. NASDAQ: INO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) common shares between February 14, 2020 and March 9, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 14, 2020 and March 9, 2020, Inovio made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.
Those who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release May 12th Deadline in Lawsuit for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) coming up here
News-ID: 2028252 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Inovio
Global Therapeutic Vaccines Market 2020 Business Strategies – Valeant Pharmace …
The market report titled “Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022” and published by Zion Market Research will put forth a systematizedevaluation of the vital facets of the global Therapeutic Vaccines Market market. The report willfunction as a medium for the better…
Global Therapeutic Vaccines Market 2020 Business Strategies – Valeant Pharmace …
The Zion Market Research added a new report “Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market…
Zika Virus Vaccines Market SWOT Analysis by Key Players: PaxVax, Takeda, Inovio …
A new business intelligence report released by HTF MI with title "Global Zika Virus Vaccines Market Insights, Forecast to 2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Zika Virus Vaccines Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative…
Investigation announced for Investors in shares of Inovio Pharmaceuticals, Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Inovio Pharmaceuticals, Inc.
Investors who are current long term investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: INO stocks follows a lawsuit filed against Inovio Pharmaceuticals,…
Lawsuit filed for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: I …
The Shareholders Foundation announced that an investor, who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO), filed a lawsuit over alleged violations of Federal Securities Laws by Inovio Pharmaceuticals, Inc..
Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and for certain investors are short and strict deadlines running. Deadline: May 12, 2020. NASDAQ: INO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Global Peptide Vaccine Market 2017 : Inovio Pharmaceuticals, Synthetic Genomics, …
Peptide Vaccine Market 2017
A market study based on the " Peptide Vaccine Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Peptide Vaccine Market 2017’. The research report analyses the historical as well as present performance of the worldwide Peptide Vaccine industry, and makes predictions on the future status of Peptide Vaccine market on the basis of this analysis.
Get Free Sample Copy of…
